Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Nov 1;327(7422):1017.
doi: 10.1136/bmj.327.7422.1017.

Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002

Iain Chalmers  1 , Cath Rounding, Kate Lock
Affiliations

Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002

Iain Chalmers et al. BMJ. .

Abstract

Objectives: To describe the characteristics of randomised controlled trials supported by the main non-commercial sources of funding in the United Kingdom between 1980 and 2002.

Design: Descriptive survey.

Setting: Randomised controlled trials funded by the Medical Research Council, NHS research and development programme, Department of Health, Chief Scientist Office in Scotland, and medical research charities.

Participants: 1464 randomised controlled trials supported by the main non-commercial sources of funding.

Results: Support for randomised controlled trials by the main sources of non-commercial funding in the United Kingdom has fallen in recent years, without any concomitant increase in the sample sizes of these studies. Drug trials in a limited range of health problems have dominated among the studies supported by the Medical Research Council and medical research charities. Until recently, the NHS research and development programme supported randomised controlled trials of various healthcare interventions, in a wide range of health problems, but between 1999 and 2002 many of the subprogrammes that had commissioned trials were discontinued.

Conclusions: The future of non-commercial randomised controlled trials in the United Kingdom has been threatened by the discontinuation or demise of national and regional NHS research and development programmes. Support also seems to be declining from the Medical Research Council and the medical research charities. It is unclear what the future holds for randomised controlled trials that address issues of no interest to industry but are of great importance to patients and practitioners.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Number of randomised controlled trials in United Kingdom supported by main non-commercial sources between 1980 and 2002, by funding body
Fig 2
Fig 2
Number of randomised controlled trials in United Kingdom supported by main non-commercial sources between 1980 and 2002, by funding body and health problem
Fig 3
Fig 3
Number of randomised controlled trials in United Kingdom supported by main non-commercial sources between 1980 and 2002, by type of intervention
See this image and copyright information in PMC

Comment in

References

    1. Medical Research Council. Clinical trials for tomorrow. London: MRC, 2002: 4. (Consultation document.)
    1. Medical Research Council. Report on the clinical trials for tomorrow review. London: MRC, 2003.
    1. Chalmers I, Rounding C, Lock K. UK RCT Registration Project: final report. Oxford: UK Cochrane Centre, 2000:appendices 3.a.i, 3.b.1, 3.c.i.
    1. Ernst E, Wider B. Medical research charities should fund more trials. BMJ 2002;325: 1245. - PMC - PubMed
    1. Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial. Lancet 2002;360: 1267-74. - PubMed

Publication types

MeSH terms